Literature DB >> 15627677

Prevalence of Aspergillus species in clinical samples isolated in an Indian tertiary care hospital.

Immaculata Xess1, Srujana Mohanty, Neena Jain, Uma Banerjee.   

Abstract

UNLABELLED: CONTEXT (BACKGROUND): In recent times, it has become important to determine the prevalence of different Aspergillus species in clinical samples in view of difference in antifungal susceptibility noted in some species. AIMS: To determine the species prevalence of Aspergillus isolates in various clinical samples received in the Mycology Laboratory at our institute.
METHOD: Over a period of 4-years, a total of 18,731 samples were processed, and species identification carried out by standard microbiological methods.
RESULTS: Four hundred and fifty six samples (2.43%) were culture positive for Aspergillus species. A.flavus (46.93%) was the most common isolate, followed by A.fumigatus (37.72%) and A.niger (15.35%). It was observed that A.fumigatus was the predominant species isolated from blood and respiratory specimens, A.flavus was predominantly isolated from nasal polyps whereas A.niger predominated in nail specimens. Culture positivity was highest in the age group 12-65 years and in males. Sixty-nine patients (15.13%) were admitted to the intensive care unit.
CONCLUSIONS: The study highlights the diverse manifestations caused by Aspergillus species in human beings and also throws light on the different species prevalent locally. The knowledge would prove useful in selecting empirical antifungal therapy and formulating prophylactic and pre-emptive strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15627677

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  6 in total

1.  Molecular Diversity of Aspergilli in Two Iranian Hospitals.

Authors:  Mohammad Javad Najafzadeh; Somayeh Dolatabadi; Hossein Zarrinfar; Jos Houbraken
Journal:  Mycopathologia       Date:  2021-05-30       Impact factor: 2.574

2.  Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates.

Authors:  Prashant Gupta; Vineeta Khare; Deepak Kumar; Abrar Ahmad; Gopa Banerjee; Mastan Singh
Journal:  J Clin Diagn Res       Date:  2015-01-01

3.  Keratitis due to Aspergillus flavus: clinical profile, molecular identification of fungal strains and detection of aflatoxin production.

Authors:  George Leema; Jayaraman Kaliamurthy; Pitchairaj Geraldine; Philip A Thomas
Journal:  Mol Vis       Date:  2010-05-11       Impact factor: 2.367

4.  Aspergillus flavus keratitis after deep anterior lamellar keratoplasty.

Authors:  Mohammad-Reza Jafarinasab; Sepehr Feizi; Forouzan Yazdizadeh; Mozhgan Rezaei Kanavi; Hamid-Reza Moein
Journal:  J Ophthalmic Vis Res       Date:  2012-04

5.  The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles.

Authors:  Husam Salah; Michaela Lackner; Jos Houbraken; Bart Theelen; Cornelia Lass-Flörl; Teun Boekhout; Muna Almaslamani; Saad J Taj-Aldeen
Journal:  Front Microbiol       Date:  2019-07-30       Impact factor: 5.640

6.  Screening for triazole resistance in clinically significant Aspergillus species; report from Pakistan.

Authors:  Safia Moin; Joveria Farooqi; Kauser Jabeen; Sidra Laiq; Afia Zafar
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-11       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.